









市場
/
株式
/
nasdaq-tmo
/

Thermo Fisher Scientific Inc

TMO

410.650USD

+6.280+1.55%

終値 06/25, 16:00（ET）15分遅れの株価

155.02B時価総額

24.47直近12ヶ月PER



Thermo Fisher Scientific Inc

410.650

+6.280+1.55%

Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, the Company provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, the Company provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Company’s Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.

企業情報

企業コードTMO

会社名Thermo Fisher Scientific Inc

上場日Aug 27, 1980

設立日1960

最高経営責任者「CEO」Mr. Marc N. Casper

従業員数125000

証券種類Ordinary Share

決算期末Aug 27

本社所在地168 Third Avenue

都市WALTHAM

証券取引所NYSE Consolidated

国United States of America

郵便番号02451

電話番号17816221000

ウェブサイトhttps://www.thermofisher.com/

企業コードTMO

上場日Aug 27, 1980

設立日1960

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Marc N. Casper

Chairman of the Board, President, Chief Executive Officer

113.96K

-33.93%

Mr. Scott M. Sperling

Lead Independent Director

73.03K

+0.78%

Mr. Stephen Williamson

Chief Financial Officer, Senior Vice President

38.30K

+26.12%

Mr. Michael D. Shafer

Executive Vice President

19.57K

-8.34%

Mr. Nelson J. Chai

Independent Director

14.48K

+4.06%

Ms. Lisa P. Britt

Chief Human Resources Officer, Senior Vice President

13.80K

+28.80%

Mr. Michel Lagarde

Chief Operating Officer, Executive Vice President

13.71K

-19.50%

Mr. Gianluca Pettiti

Executive Vice President

13.09K

-2.96%

Mr. Michael A. Boxer

Senior Vice President, General Counsel

8.87K

-29.85%

Dr. Tyler Jacks

Director

8.62K

+7.01%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Marc N. Casper

Chairman of the Board, President, Chief Executive Officer

113.96K

-33.93%

Mr. Scott M. Sperling

Lead Independent Director

73.03K

+0.78%

Mr. Stephen Williamson

Chief Financial Officer, Senior Vice President

38.30K

+26.12%

Mr. Michael D. Shafer

Executive Vice President

19.57K

-8.34%

Mr. Nelson J. Chai

Independent Director

14.48K

+4.06%

Ms. Lisa P. Britt

Chief Human Resources Officer, Senior Vice President

13.80K

+28.80%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Service

17.84B

41.62%

Consumables

17.59B

41.02%

Instruments

7.45B

17.37%

地域別USD

会社名

収益

比率

United States

21.75B

50.74%

Europe

10.86B

25.32%

Asia Pacific

7.96B

18.55%

Other Regions

1.56B

3.64%

Northern America excluded united states

749.00M

1.75%

事業別

地域別

事業別USD

会社名

収益

比率

Service

17.84B

41.62%

Consumables

17.59B

41.02%

Instruments

7.45B

17.37%

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

8.82%

BlackRock Institutional Trust Company, N.A.

4.58%

State Street Global Advisors (US)

4.38%

Capital World Investors

2.93%

T. Rowe Price Associates, Inc.

2.32%

Other

76.97%

株主統計

比率

The Vanguard Group, Inc.

8.82%

BlackRock Institutional Trust Company, N.A.

4.58%

State Street Global Advisors (US)

4.38%

Capital World Investors

2.93%

T. Rowe Price Associates, Inc.

2.32%

Other

76.97%

種類

株主統計

比率

Investment Advisor

42.93%

Investment Advisor/Hedge Fund

37.30%

Bank and Trust

2.98%

Research Firm

2.77%

Pension Fund

2.42%

Sovereign Wealth Fund

2.06%

Hedge Fund

1.74%

Family Office

0.23%

Family Office

0.20%

Other

7.37%

機関投資家保有株

更新時刻: Thu, Feb 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

4336

350.18M

92.75%

-1.84M

2024Q4

4330

349.72M

92.67%

-4.90M

2024Q3

4195

348.49M

91.10%

-6.75M

2024Q2

4169

349.06M

91.37%

-3.26M

2024Q1

4150

346.74M

90.80%

-11.10M

2023Q4

4145

353.49M

91.48%

-3.65M

2023Q3

4035

353.30M

91.43%

-5.83M

2023Q2

4030

357.37M

92.63%

+1.15M

2023Q1

3992

353.61M

91.65%

-5.21M

2022Q4

3961

356.99M

91.02%

-2.42M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

33.08M

8.77%

+201.59K

+0.61%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

17.20M

4.56%

+65.72K

+0.38%

Dec 31, 2024

State Street Global Advisors (US)

16.45M

4.36%

+129.07K

+0.79%

Dec 31, 2024

Capital World Investors

9.43M

2.5%

+104.34K

+1.12%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.33M

2.74%

-64.57K

-0.62%

Dec 31, 2024

Geode Capital Management, L.L.C.

7.86M

2.08%

+197.44K

+2.58%

Dec 31, 2024

Capital Research Global Investors

7.92M

2.1%

-266.96K

-3.26%

Dec 31, 2024

JP Morgan Asset Management

5.66M

1.5%

+1.37M

+31.89%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

6.05M

1.6%

+483.36K

+8.68%

Dec 31, 2024

Morgan Stanley Smith Barney LLC

4.45M

1.18%

+797.00

+0.02%

Dec 31, 2024

詳細を見る

関連ETF

更新時刻: Fri, Jun 6

銘柄名

比率

Monarch Blue Chips Core ETF

4.6%

AdvisorShares Focused Equity ETF

3.77%

Amplify Weight Loss Drug & Treatment ETF

3.66%

Honeytree US Equity ETF

3.33%

Health Care Select Sector SPDR Fund

3.01%

Putnam Focused Large Cap Value ETF

2.98%

Brookstone Value Stock ETF

2.91%

Proshares Ultra Health Care

2.91%

iShares U.S. Healthcare ETF

2.88%

Tema Monopolies and Oligopolies ETF

2.62%

詳細を見る

Monarch Blue Chips Core ETF

比率4.6%

AdvisorShares Focused Equity ETF

比率3.77%

Amplify Weight Loss Drug & Treatment ETF

比率3.66%

Honeytree US Equity ETF

比率3.33%

Health Care Select Sector SPDR Fund

比率3.01%

Putnam Focused Large Cap Value ETF

比率2.98%

Brookstone Value Stock ETF

比率2.91%

Proshares Ultra Health Care

比率2.91%

iShares U.S. Healthcare ETF

比率2.88%

Tema Monopolies and Oligopolies ETF

比率2.62%

配当金

過去5年間の配当金総支払額は 2.29B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Feb 19, 2025

TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025

Mar 14, 2025

Apr 15, 2025

Mar 14, 2025

Nov 07, 2024

TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024

Dec 13, 2024

Jan 15, 2025

Dec 13, 2024

Jul 11, 2024

TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024

Sep 13, 2024

Oct 15, 2024

Sep 13, 2024

May 22, 2024

TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jul 15, 2024

Jun 14, 2024

Feb 21, 2024

TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Apr 15, 2024

Mar 14, 2024

Nov 09, 2023

TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023

Dec 15, 2023

Jan 16, 2024

Dec 14, 2023

Jul 13, 2023

TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023

Sep 15, 2023

Oct 13, 2023

Sep 14, 2023

May 24, 2023

TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023

Jun 15, 2023

Jul 14, 2023

Jun 14, 2023

Feb 22, 2023

TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Apr 14, 2023 going ex on Mar 14, 2023

Mar 15, 2023

Apr 14, 2023

Mar 14, 2023

Nov 10, 2022

TMO.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 16, 2023 going ex on Dec 14, 2022

Dec 15, 2022

Jan 16, 2023

Dec 14, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

KeyAI



Thermo Fisher Scientific Inc

410.650USD

Thermo Fisher Scientific Inc

410.650

概要

企業名